Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2017 Filed Sep 6, 2017 20:01 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.37 | $25,925.00 |
DisclosureSEC source: 0001127602-17-027107 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,736 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.14 to $10.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 29, 2017 Filed Aug 29, 2017 21:30 UTC |
Marchio Albert N IIChief Accounting & Adm Officer
|
SaleCommon Stock | 2,500 | $10.42 | $26,050.00 |
DisclosureSEC source: 0001127602-17-026651 · form4.xml · nonDerivative · entry 1 MARCHIO ALBERT N II · CIK 0001196054 · Chief Accounting & Adm Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,361 F1 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.47 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:11 UTC |
Marchio Albert N IIChief Accounting & Adm Officer
|
SaleCommon Stock | 1,000 | $10.39 | $10,390.00 |
DisclosureSEC source: 0001127602-17-026402 · form4.xml · nonDerivative · entry 1 MARCHIO ALBERT N II · CIK 0001196054 · Chief Accounting & Adm Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,861 Read SEC document |
| August 03, 2017 Filed Aug 3, 2017 20:45 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.40 | $26,000.00 |
DisclosureSEC source: 0001127602-17-024929 · form4.xml · nonDerivative · entry 3 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,236 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.16 to $10.61 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 20:45 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.53 | $26,325.00 |
DisclosureSEC source: 0001127602-17-024929 · form4.xml · nonDerivative · entry 2 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,736 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.41 to $10.72 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:45 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.65 | $26,625.00 |
DisclosureSEC source: 0001127602-17-024929 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,236 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.54 to $10.85 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 07, 2017 Filed Jul 10, 2017 19:51 UTC |
BARER SOL JDirector
|
OtherWarrants (right To Purchase) · Derivative | 12,530 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001127602-17-023418 · form4.xml · derivative · entry 2 BARER SOL J · CIK 0001247015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 12,530 shares Expires 2017-10-23 F2 · ownership.direct: These shares are held by Meryl Barer, the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. F2 · ownership.nature: These shares are held by Meryl Barer, the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| July 07, 2017 Filed Jul 10, 2017 19:51 UTC |
BARER SOL JDirector
|
OtherCommon Stock | 12,530 | $2.39 | $29,946.70 |
DisclosureSEC source: 0001127602-17-023418 · form4.xml · nonDerivative · entry 1 BARER SOL J · CIK 0001247015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 658,075 F1 · ownership.direct: These shares are held by Meryl Barer, the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. F1 · ownership.nature: These shares are held by Meryl Barer, the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| July 06, 2017 Filed Jul 6, 2017 17:50 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.08 | $25,200.00 |
DisclosureSEC source: 0001127602-17-023286 · form4.xml · nonDerivative · entry 3 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,736 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.22 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 17:50 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.21 | $25,525.00 |
DisclosureSEC source: 0001127602-17-023286 · form4.xml · nonDerivative · entry 2 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,236 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.33 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 17:50 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 2,500 | $10.27 | $25,675.00 |
DisclosureSEC source: 0001127602-17-023286 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,736 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.48 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 14:28 UTC |
BLECH ISAACDirector
|
GrantStock Option (right To Purchase) · Derivative | 15,000 | $10.15 Strike: $10.15 | $152,250.00 |
DisclosureSEC source: 0001127602-17-021957 · form4.xml · derivative · entry 1 BLECH ISAAC · CIK 0000905536 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 18:17 UTC |
Spiegel Robert J.Director
|
GrantStock Option (right To Purchase) · Derivative | 15,000 | $10.15 Strike: $10.15 | $152,250.00 |
DisclosureSEC source: 0001127602-17-021947 · form4.xml · derivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 18:32 UTC |
BARER SOL JDirector
|
GrantStock Option (right To Purchase) · Derivative | 30,000 | $10.15 Strike: $10.15 | $304,500.00 |
DisclosureSEC source: 0001127602-17-021960 · form4.xml · derivative · entry 1 BARER SOL J · CIK 0001247015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-06-20 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 18:26 UTC |
Conti Kurt GDirector
|
GrantStock Option (right To Purchase) · Derivative | 15,000 | $10.15 Strike: $10.15 | $152,250.00 |
DisclosureSEC source: 0001127602-17-021955 · form4.xml · derivative · entry 1 Conti Kurt G · CIK 0001653204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 18:24 UTC |
HEALY JAMESDirector
|
GrantStock Option (right To Purchase) · Derivative | 15,000 | $10.15 Strike: $10.15 | $152,250.00 |
DisclosureSEC source: 0001127602-17-021953 · form4.xml · derivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 18:22 UTC |
LOUGHLIN JAMES JDirector
|
GrantStock Option (right To Purchase) · Derivative | 15,000 | $10.15 Strike: $10.15 | $152,250.00 |
DisclosureSEC source: 0001127602-17-021951 · form4.xml · derivative · entry 1 LOUGHLIN JAMES J · CIK 0001276550 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 18:19 UTC |
Ratcliffe LiamDirector
|
GrantStock Option (right To Purchase) · Derivative | 15,000 | $10.15 Strike: $10.15 | $152,250.00 |
DisclosureSEC source: 0001127602-17-021949 · form4.xml · derivative · entry 1 Ratcliffe Liam · CIK 0001547100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 Read SEC document |
| April 26, 2017 Filed May 9, 2017 15:33 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 100 | $11.10 | $1,110.00 |
DisclosureSEC source: 0001127602-17-017360 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,236 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 19:36 UTC |
Macdonald R. LochDirector · Chief Scientific Officer
|
GrantStock Option (right To Purchase) · Derivative | 110,000 | $8.86 Strike: $8.86 | $974,600.00 |
DisclosureSEC source: 0001127602-17-011770 · form4.xml · derivative · entry 1 Macdonald R. Loch · CIK 0001653008 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2027-03-13 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 110,000 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 15:30 UTC |
Leuthner Brian ADirector · President and CEO
|
GrantStock Option (right To Purchase) · Derivative | 267,500 | $8.86 Strike: $8.86 | $2,370,050.00 |
DisclosureSEC source: 0001127602-17-011765 · form4.xml · derivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,500 Underlying: Common Stock · 267,500 shares Expires 2027-03-13 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 267,500 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 15:23 UTC |
Faleck Herbert JChief Medical Officer
|
GrantStock Option (right To Purchase) · Derivative | 110,000 | $8.86 Strike: $8.86 | $974,600.00 |
DisclosureSEC source: 0001127602-17-011763 · form4.xml · derivative · entry 1 Faleck Herbert J · CIK 0001652994 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2027-03-13 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 110,000 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 19:32 UTC |
Marchio Albert N IIChief Accounting & Ops Officer
|
GrantStock Option (right To Purchase) · Derivative | 47,500 | $8.86 Strike: $8.86 | $420,850.00 |
DisclosureSEC source: 0001127602-17-011767 · form4.xml · derivative · entry 1 MARCHIO ALBERT N II · CIK 0001196054 · Chief Accounting & Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2027-03-13 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 47,500 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 19:38 UTC |
MIDDLEKAUFF W BRADFORDSenior VP, GC and Secretary
|
GrantStock Option (right To Purchase) · Derivative | 52,500 | $8.86 Strike: $8.86 | $465,150.00 |
DisclosureSEC source: 0001127602-17-011772 · form4.xml · derivative · entry 1 MIDDLEKAUFF W BRADFORD · CIK 0001214501 · Senior VP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2027-03-13 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 52,500 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 19:20 UTC |
Yaman AlpaslanV.P., Technical Ops. & Mfg.
|
GrantStock Option (right To Purchase) · Derivative | 40,000 | $8.86 Strike: $8.86 | $354,400.00 |
DisclosureSEC source: 0001127602-17-011761 · form4.xml · derivative · entry 1 Yaman Alpaslan · CIK 0001653707 · V.P., Technical Ops. & Mfg. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-03-13 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 40,000 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 20:33 UTC |
LOUGHLIN JAMES JDirector
|
PurchaseCommon Stock | 3,000 | $9.24 | $27,720.00 |
DisclosureSEC source: 0001127602-17-010543 · form4.xml · nonDerivative · entry 1 LOUGHLIN JAMES J · CIK 0001276550 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 6,000 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 15:57 UTC |
Wyant AlyssaSVP Regulatory Affairs
|
GrantStock Option (right To Purchase) · Derivative | 80,000 | $9.81 Strike: $9.81 | $784,800.00 |
DisclosureSEC source: 0001127602-17-009471 · form4.xml · derivative · entry 1 Wyant Alyssa · CIK 0001698765 · SVP Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-02-28 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 80,000 shares of Common Stock, will become exercisable on February 21, 2018, with a 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 01, 2017 Filed Mar 13, 2017 17:47 UTC |
Einhorn Andrew J.Chief Financial Officer
|
OtherWarrants (right To Purchase) · Derivative | 1,567 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001127602-17-011377 · form4.xml · derivative · entry 3 Einhorn Andrew J. · CIK 0001560685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,567 shares Expires 2017-09-09 Read SEC document |
| March 01, 2017 Filed Mar 13, 2017 17:47 UTC |
Einhorn Andrew J.Chief Financial Officer
|
OtherCommon Stock | 1,567 | $2.39 | $3,745.13 |
DisclosureSEC source: 0001127602-17-011377 · form4.xml · nonDerivative · entry 1 Einhorn Andrew J. · CIK 0001560685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,223 Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 15:53 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 1,500 | $9.52 | $14,280.00 |
DisclosureSEC source: 0001127602-17-004564 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,479 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.62 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 16:12 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 1,500 | $9.52 | $14,280.00 |
DisclosureSEC source: 0001127602-17-004341 · form4.xml · nonDerivative · entry 2 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,979 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.40 to $9.59 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 16:12 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 1,500 | $9.69 | $14,535.00 |
DisclosureSEC source: 0001127602-17-004341 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,479 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.82 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 15:25 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 1,500 | $9.61 | $14,415.00 |
DisclosureSEC source: 0001127602-17-003847 · form4.xml · nonDerivative · entry 2 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,979 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.46 to $9.80 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 15:25 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 1,500 | $9.38 | $14,070.00 |
DisclosureSEC source: 0001127602-17-003847 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,479 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.16 to $9.63 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 14:35 UTC |
Macdonald R. LochDirector · Chief Scientific Officer
|
Exercise / conversionStock Option (right To Purchase) · Derivative | 25,000 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001127602-17-002309 · form4.xml · derivative · entry 2 Macdonald R. Loch · CIK 0001653008 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,504 Underlying: Common Stock · 25,000 shares Expires 2023-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option, representing a right to purchase a total of 100,504 shares of Common Stock, became exercisable on June 1, 2014, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 14:35 UTC |
Macdonald R. LochDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 25,000 | $2.04 | $51,000.00 |
DisclosureSEC source: 0001127602-17-002309 · form4.xml · nonDerivative · entry 1 Macdonald R. Loch · CIK 0001653008 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 595,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 15:00 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 7,500 | $11.60 | $87,000.00 |
DisclosureSEC source: 0001127602-16-068954 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,979 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $11.11 to $12.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 17:44 UTC |
BRENNAN DANIELChief Operating Officer
|
GrantStock Option (right To Purchase) · Derivative | 150,000 | $10.09 Strike: $10.09 | $1,513,500.00 |
DisclosureSEC source: 0001127602-16-065820 · form4.xml · derivative · entry 1 BRENNAN DANIEL · CIK 0001657999 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-10-31 F1 · derivative.exercise_date: This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on October 17, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 11:16 UTC |
Leuthner Brian ADirector · President and CEO
|
SaleCommon Stock | 7,500 | $10.25 | $76,844.25 |
DisclosureSEC source: 0001127602-16-063859 · form4.xml · nonDerivative · entry 1 Leuthner Brian A · CIK 0001652973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,479 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.02 to $10.53 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.